Mayne Pharma Group Ltd

Here is the public summary page for Mayne Pharma Group Ltd. Please login to see the complete information for Mayne Pharma Group Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Mayne Pharma Group Ltd stacks up relative to its peers.


Darwin Score-2
TickerMYX
Latest Price4.95 AUD as of close on 31-Jul-2025
3 Month price range4.35 to 7.12 AUD
Market Capitalisation411.92Mn AUD
CountryAustralia
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryPharmaceuticals
Sub-IndustryPharmaceuticals
Description
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women's Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
See More ...
Company URLhttps://www.maynepharma.com
See Darwins Full Analysis for Mayne Pharma Group Ltd

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Mayne Pharma Group Ltd. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages0
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.+5
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-8

Peer Comparison

There are 3 peers of Mayne Pharma Group Ltd.
Asset NameIndustry GroupPerf(20d)%Asset Score
Ecofibre Ltd (EOF)Pharmaceuticals0-9
Medical Developments International Ltd (MVP)Pharmaceuticals+5.2+19
Starpharma Holdings Ltd (SPL)Pharmaceuticals+8.7-11

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn